| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/26/2006 | CN1807448A Corn protein powder polypeptide for suppressing weed germination and rootage, and its separation method and uses |
| 07/26/2006 | CN1266275C Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 07/26/2006 | CN1265839C Glycoconjugates obtained from i(candide Utilis) cells and i(Ricinus)i(communis) seeds |
| 07/25/2006 | US7081523 And stimulate erythropoiesis; teatment of anemia |
| 07/25/2006 | US7081522 Gene causative of Rothmund-Thomson syndrome and gene product |
| 07/25/2006 | US7081521 Anti-PRO788 antibodies |
| 07/25/2006 | US7081520 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/25/2006 | US7081518 For the diagnosis and therapy of cancers of the ovary, stomach, squamous cells, mesotheliomas and other malignant cells expressing mesothelin |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081359 Recombinant bacillus proteases and uses thereof |
| 07/25/2006 | US7081358 Method for engineering strand-specific, sequence-specific, DNA-nicking enzymes |
| 07/25/2006 | US7081354 Interleukin and albumin fusion protein |
| 07/25/2006 | US7081341 A plasmid containing an rRNA gene having a mutant Anti-Shine-Dalgarno sequence, at least one mutation in such rRNA gene, and a genetically engineered gene which encodes a selectable marker having a mutant Shine-Dalgarno sequence |
| 07/25/2006 | CA2333966C Media for culturing animal cells and process for producing protein by using the same |
| 07/25/2006 | CA2206423C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 07/25/2006 | CA2188264C Isolated nucleic acid molecule coding for fibroblast activation protein .alpha. and uses thereof |
| 07/25/2006 | CA2156935C Methods of detecting collagen degradation in vivo |
| 07/20/2006 | WO2006076741A2 Canine 5-hydroxytryptamine 2a and 2b receptor materials and thier use |
| 07/20/2006 | WO2006076517A1 Attenuated mycobacteria as vectors for gene delivery to mammalian cells |
| 07/20/2006 | WO2006076343A1 Mycobacteria expressing hiv-1 and malaria antigens |
| 07/20/2006 | WO2006076041A2 Pan-her antagonists and methods of use |
| 07/20/2006 | WO2006075784A1 ANTI-α9 INTEGRIN ANTIBODY AND THE USE THEREOF |
| 07/20/2006 | WO2006075668A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES |
| 07/20/2006 | WO2006075486A1 Mutant protein having peptide-production activity |
| 07/20/2006 | WO2006074914A2 Human rna helicase and therapeutic uses thereof |
| 07/20/2006 | WO2006033811A3 Ilt3 polypeptides and uses thereof |
| 07/20/2006 | WO2005120700A3 Peptide purification by means of hard metal ion affinity chromatography |
| 07/20/2006 | WO2005093103A3 Development and use of fluorescent probes of unbound analytes |
| 07/20/2006 | WO2005081926A3 Thrombomodulin derivatives and conjugates |
| 07/20/2006 | WO2004007672A3 Methods and materials relating to novel polypeptides and polynucleotides |
| 07/20/2006 | US20060162006 Polynucleotides and polypeptides in plants |
| 07/20/2006 | US20060161997 Methods for producing human antibodies in SCID mice |
| 07/20/2006 | US20060161996 Process for producing human-origin immunocompetent cell |
| 07/20/2006 | US20060161995 Chimeric mouse in which at least 85% of the human antibody-producing cells retain the human artificial chromosome Delta HAC or Delta Delta HAC. |
| 07/20/2006 | US20060160998 Methods for isolation and purification of fluorochrome-antibody conjugates |
| 07/20/2006 | US20060160997 Tumor-associated antigen specific immunoglobulin fusion for use in diagnosis, prevention and treatment of cell proliferative |
| 07/20/2006 | US20060160992 Method of identifying cells expressing a protein having pre-B cell growth-supporting ability |
| 07/20/2006 | US20060160991 Genes and polypeptides relating to prostate cancers |
| 07/20/2006 | US20060160990 Fluorescent protein and chromoprotein |
| 07/20/2006 | US20060160738 Stem cell factor-like proteins and uses thereof |
| 07/20/2006 | US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 07/20/2006 | US20060160700 Nadh-dependent cytochrome b5 reductase as target for herbicides |
| 07/20/2006 | US20060160233 Ig heavy chain, ig kappa, ig lambda biopolymer markers predictive of alzheimers disease |
| 07/20/2006 | US20060160232 Complement c3 precursor biopolymer markers predictive of type ii diabetes |
| 07/20/2006 | US20060160193 Suitable for use in the manufacture of microbial oils enriched in omega fatty acids in oleaginous yeast (e.g., Yarrowia lipolytica) |
| 07/20/2006 | US20060160187 Combinatorial interleukin-2 muteins |
| 07/20/2006 | US20060160186 Nucleic acid underexpressed in stomach tumor and lung tumor |
| 07/20/2006 | US20060160185 Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs |
| 07/20/2006 | US20060160184 Fab library for the preparation of anti VEGF and anti rabies virus fabs |
| 07/20/2006 | US20060160183 Vaccines and immunotherapeutics derived from the human immunodeficiency virus (hiv) transactivator of transcription protein for the treatment and prevention of hiv disease |
| 07/20/2006 | US20060160182 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production |
| 07/20/2006 | US20060160181 Fibroblast Growth Factor-23 molecules and uses thereof |
| 07/20/2006 | US20060160180 Control and optimization of cell culture conditions is critically important for successful commercial production of proteins and polypeptides; changing the culture from a first set of culture conditions to a second set of culture conditions so that a metabolic shift of the cells is achieved |
| 07/20/2006 | US20060160179 Filamentous fungal host cells to produce glycans without mannosylphosphate residues, therapy |
| 07/20/2006 | US20060160178 Methods of generating antibody diversity in vitro |
| 07/20/2006 | US20060160177 Peptide extended glycosylated polypeptides |
| 07/20/2006 | US20060160176 High throughput cell-based functional assays and using cells, e.g., HEK-293 cells that express a G protein such as G alpha 15, G alpha 16 or gustducin. |
| 07/20/2006 | US20060160175 Compositions of orthogonal leucyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 07/20/2006 | US20060160174 Modified l49-sfv exhibiting increased stability and methods of use thereof |
| 07/20/2006 | US20060160173 Compared with a homoserine transsuccinylase wild-type enzyme, exhibits a reduced sensitivity toward L-methionine or S-Adenosylmethionine, with the wild-type enzyme possessing an amino acid sequence which comprises a constituent sequence TyrGlnXaaThrPro, with the Thr at position 297 onward being replaced |
| 07/20/2006 | US20060160172 Sqs gene |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160157 Method, compositions and classification for tumor diagnostics and treatment |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160152 Protein for use in the treatment of inflammation, allergies, asthma and leukemias |
| 07/20/2006 | US20060160150 Solid phase synthesis; antibodies; kits |
| 07/20/2006 | US20060160147 Recombinant cell line |
| 07/20/2006 | US20060160146 Method of screening compound affecting amyloid beta production |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
| 07/20/2006 | US20060160142 Phosophoinositoglycan binding proteins |
| 07/20/2006 | US20060160141 Peptide sequence tags and method of using same |
| 07/20/2006 | US20060160140 Human nuclear receptor protein nNR7-1 |
| 07/20/2006 | US20060160139 Rhesus BCRP and antibodies thereto |
| 07/20/2006 | US20060160133 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 07/20/2006 | US20060160128 Novel adenosine deaminase homolog |
| 07/20/2006 | US20060160126 90 human secreted proteins |
| 07/20/2006 | US20060160108 Populations of reporter sequences and methods of their use |
| 07/20/2006 | US20060160103 Mammalian neuralized family transcriptional regulators and uses |
| 07/20/2006 | US20060160092 useful for evaluating actin cytoskeleton-controlling agents; as a functional marker of the intercalate disc for heart diseases, such as myocardial infarction and myocarditis, due to its extremely high expression at the intercalate disc of cardiac muscle cells |
| 07/20/2006 | US20060160091 Polynucleotides encoding a class II cytokine receptor |
| 07/20/2006 | US20060160090 Composition splice variants and methods relating to cancer specific genes and proteins |
| 07/20/2006 | US20060160082 Novel genes and proteins encoded thereby |
| 07/20/2006 | US20060160072 using modified vaccinia topoisomerase enzyme containing an affinity tag to facilitate purification of protein-DNA complexes away from unbound DNA; ligating duplex DNAs; cloning DNA by introducing into a cell ligated duplex DNA |
| 07/20/2006 | US20060159709 Recombinant high molecular weight major outer membrane protein of moraxella |
| 07/20/2006 | US20060159707 Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses |
| 07/20/2006 | US20060159697 Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 07/20/2006 | US20060159691 Ptprk immunogenic peptide |
| 07/20/2006 | US20060159685 Of given sequence; immunomodulators; prophylaxis or treatments for cancers |
| 07/20/2006 | US20060159683 Stabilization of chimeric immunoglobulin; obtain immunoglobulin, monitor structure, determine sequence, adjust amino acid sequences for greater stability |
| 07/20/2006 | US20060159682 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof |
| 07/20/2006 | US20060159675 Compositions and methods for treating coagulation related disorders |
| 07/20/2006 | US20060159673 Methods of screening light chain of antibody |
| 07/20/2006 | US20060159656 Formulations for IL-11 |
| 07/20/2006 | US20060159654 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE |
| 07/20/2006 | CA2593777A1 Anti-.alpha.9 integrin antibody and the use thereof |
| 07/20/2006 | CA2592309A1 Mutant protein having peptide-synthesizing activity |
| 07/19/2006 | EP1681350A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 07/19/2006 | EP1681349A2 Genetic control of plant growth and development |
| 07/19/2006 | EP1681348A1 MU-1 member of the cytokine receptor family |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |